Apcotex Industries Reports Strong Q4 and Full-Year FY26 Resu...
Source: scanx.trade
Park Medi World Limited has announced the incorporation of a new step-down subsidiary focused on healthcare and ancillary services, pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure was made on May 04, 2026, and signed by Abhishek Kapoor, Company Secretary & Compliance Officer.
Proposed Subsidiary Details
The new entity is proposed to be named Healplus Medical Services Private Limited or Healplus Healthcare Private Limited, subject to approval by the Ministry of Corporate Affairs. The incorporation is yet to be completed, and the country of incorporation will be India. The proposed entity will operate in the healthcare services sector, dealing in healthcare and ancillary business lines.
The following table summarises the key details of the proposed incorporation as disclosed under the applicable SEBI regulations:
Parameter: Details Proposed Entity Name: Healplus Medical Services Private Limited or Healplus Healthcare Private Limited (subject to MCA approval) Date of Incorporation: To be incorporated Country of Incorporation: India Industry: Healthcare services Holding Company: Park Medicenters & Institutions Private Limited Relation to Listed Entity: Step-down subsidiary Nature of Consideration: Cash Cost of Subscription: INR 0.01 crore Regulatory Approvals Required: Not required
Corporate Structure and Shareholding
The proposed entity will be a wholly-owned subsidiary of Park Medicenters & Institutions Private Limited, which is an existing subsidiary of Park Medi World Limited. Consequently, the new entity will function as a step-down subsidiary of the listed company. Park Medi World Limited currently holds 81.81% equity shareholding in Park Medicenters & Institutions Private Limited.
The subscription to the shares of the proposed entity will be made through a cash consideration of INR 0.01 crore, to be paid by Park Medicenters & Institutions Private Limited along with its nominee.
Regulatory Compliance
The disclosure has been made in accordance with Regulation 30 of the SEBI Listing Regulations, read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026. No governmental or regulatory approvals are required for the incorporation of the proposed entity. The disclosure has also been disseminated on the company's official website at www.parkhospital.in .
Park medi world has attracted institutional investment from Vikas Khemani's Carnelian Bharat Amritkaal Fund, which has acquired a 1.04% stake in the company during the fourth quarter. This development highlights the growing institutional interest in the healthcare sector and Park Medi World's business operations.
Investment Details
The stake acquisition represents a notable addition to Park Medi World's institutional investor base. Carnelian Bharat Amritkaal Fund, managed by seasoned investor Vikas Khemani, has strategically positioned itself in the company with this investment.
Investment Parameter: Details Fund Name: Carnelian Bharat Amritkaal Fund Fund Manager: Vikas Khemani Stake Acquired: 1.04% Investment Period: Q4
Significance for Park Medi World
The investment from Carnelian Bharat Amritkaal Fund adds credibility to Park Medi World's growth story and business fundamentals. Vikas Khemani's reputation as an experienced investor in the Indian market makes this stake acquisition particularly noteworthy for existing and potential shareholders.
This institutional investment could potentially enhance the company's visibility among other institutional investors and contribute to improved market perception of Park Medi World's prospects in the healthcare sector.
We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.
Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.
Disclaimer:
The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.
Source: scanx.trade
Source: The Economic Times